MALVERN, Pa., Sept. 18, 2023 Galera Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that.
Galera Therapeutics, Inc. (NASDAQ:GRTX – Get Free Report) saw a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 3,360,000 shares, a growth of 128.6% from the July 31st total of 1,470,000 shares. Approximately 9.4% of the company’s shares are short sold. Based on an […]
Galera Therapeutics, Inc. (NASDAQ:GRTX – Get Free Report) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 3,360,000 shares, an increase of 128.6% from the July 31st total of 1,470,000 shares. Approximately 9.4% of the shares of the stock are sold short. Based […]
Galera Therapeutics (NASDAQ:GRTX) Stock Rating Lowered by Citigroup theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Galera Therapeutics (NASDAQ:GRTX – Get Free Report) was downgraded by equities researchers at HC Wainwright from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, MarketBeat.com reports. Several other analysts also recently commented on GRTX. Citigroup downgraded shares of Galera Therapeutics from a “buy” rating to a “neutral” rating […]